Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies

OBJECTIVE: The objective of this study was to confirm the efficacy of low-dose mizoribine (MZR), an inhibitor of inosine monophosphate dehydrogenase, as part of synchronized methotrexate (MTX) therapy for rheumatoid arthritis (RA) patients with an inadequate response to various combination therapies...

全面介紹

Na minha lista:
書目詳細資料
發表在:Intern Med
Main Authors: Ikeda, Keigo, Watanabe, Kozo, Hirai, Takuya, Tanji, Kana, Miyashita, Tomoko, Nakajima, Shihoko, Uomori, Kaori, Morimoto, Shinji, Takamori, Kenji, Ogawa, Hideoki, Takasaki, Yoshinari, Sekigawa, Iwao
格式: Artigo
語言:Inglês
出版: The Japanese Society of Internal Medicine 2017
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5491807/
https://ncbi.nlm.nih.gov/pubmed/28502927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.56.7886
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍